[1] |
WANG Zhiqing, LIU Xiyu, FAN Lei.
Advances and controversies in the adjuvant treatment of early breast cancer
[J]. China Oncology, 2025, 35(3): 255-262.
|
[2] |
YANG Xin, SHI Qianfeng, LIU Qiang.
Progress of important clinical research on breast cancer in China in 2024
[J]. China Oncology, 2025, 35(2): 167-175.
|
[3] |
LI Xing, PENG Ziqi, YU Xinmiao, JIN Feng.
Important research progress in clinical practice for early breast cancer in 2024
[J]. China Oncology, 2025, 35(2): 176-185.
|
[4] |
WANG Ting, QIN Yi, XU Xiaowu, YU Xianjun.
New advances in basic research, clinical diagnosis and treatment of pancreatic cancer in 2024
[J]. China Oncology, 2025, 35(1): 1-11.
|
[5] |
HAO Xian, HUANG Jianjun, YANG Wenxiu, LIU Jinting, ZHANG Junhong, LUO Yubei, LI Qing, WANG Dahong, GAO Yuwei, TAN Fuyun, BO Li, ZHENG Yu, WANG Rong, FENG Jianglong, LI Jing, ZHAO Chunhua, DOU Xiaowei.
Establishment of primary breast cancer cell line as new model for drug screening and basic research
[J]. China Oncology, 2024, 34(6): 561-570.
|
[6] |
CHEN Hong, CAO Zhiyun.
Recent progress in the construction and application of patient-derived pancreatic cancer organoid models
[J]. China Oncology, 2024, 34(6): 590-597.
|
[7] |
ZHANG Qi, XIU Bingqiu, WU Jiong.
Progress of important clinical research of breast cancer in China in 2023
[J]. China Oncology, 2024, 34(2): 135-142.
|
[8] |
WANG Zhaobu, LI Xing, YU Xinmiao, JIN Feng.
Important research progress in clinical practice for early breast cancer in 2023
[J]. China Oncology, 2024, 34(2): 151-160.
|
[9] |
REN Jiaqiang, WU Shuai, SU Tong, LI Jie, HAN Liang, WU Zheng.
An exploratory study of INPP4B, a biomarker of gemcitabine chemoresistance in pancreatic cancer
[J]. China Oncology, 2024, 34(12): 1090-1099.
|
[10] |
TAN Xiaolang, YAO Sha, WANG Guihua, PENG Luogen.
Research on uPAR promoting proliferation, migration, and chemoresistance of pancreatic cancer by inhibiting autophagy via MAPK signaling
[J]. China Oncology, 2024, 34(10): 944-956.
|
[11] |
LI Tianjiao, YE Longyun, JIN Kaizhou, WU Weiding, YU Xianjun.
Advances in basic research, clinical diagnosis and treatment of pancreatic cancer in 2023
[J]. China Oncology, 2024, 34(1): 1-12.
|
[12] |
QU Ning, WANG Yuting, MA Ben, WANG Yu.
Advances in basic research, clinical diagnosis and treatment of thyroid cancer in 2022
[J]. China Oncology, 2023, 33(5): 423-430.
|
[13] |
JIANG Jinling, ZHOU Chenfei, WANG Chao, ZHAO Liqin, WU Junwei, ZHANG Jun.
Advanced progress in research and diagnosis of gastric cancer in 2022
[J]. China Oncology, 2023, 33(4): 303-314.
|
[14] |
ZHAO Haichao, GAO Qiang.
Progress in research, diagnosis, and treatment of hepatocellular carcinoma in 2022
[J]. China Oncology, 2023, 33(4): 315-326.
|
[15] |
TIAN Xi, XU Wenhao, ZHU Shuxuan, AIHETAIMUJIANG•Anwaier, SU Jiaqi, YE Shiqi, QU Yuanyuan, SHI Guohai, ZHANG Hailiang, YE Dingwei.
Advances in the research, diagnosis and treatment of renal cell carcinoma in 2022
[J]. China Oncology, 2023, 33(3): 191-200.
|